Cargando…
Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model
BACKGROUND: Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments. RESEARCH QUESTION: Can we de...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Southern Society for Clinical Investigation. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141270/ https://www.ncbi.nlm.nih.gov/pubmed/34029558 http://dx.doi.org/10.1016/j.amjms.2021.04.001 |
_version_ | 1783696331179556864 |
---|---|
author | Woo, Sang H. Rios-Diaz, Arturo J. Kubey, Alan A. Cheney-Peters, Dianna R. Ackermann, Lily L. Chalikonda, Divya M. Venkataraman, Chantel M. Riley, Joshua M. Baram, Michael |
author_facet | Woo, Sang H. Rios-Diaz, Arturo J. Kubey, Alan A. Cheney-Peters, Dianna R. Ackermann, Lily L. Chalikonda, Divya M. Venkataraman, Chantel M. Riley, Joshua M. Baram, Michael |
author_sort | Woo, Sang H. |
collection | PubMed |
description | BACKGROUND: Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments. RESEARCH QUESTION: Can we develop and validate a web-based risk prediction model for identification of patients who may develop severe COVID-19, defined as intensive care unit (ICU) admission, mechanical ventilation, and/or death? METHODS: This retrospective cohort study reviewed 415 patients admitted to a large urban academic medical center and community hospitals. Covariates included demographic, clinical, and laboratory data. The independent association of predictors with severe COVID-19 was determined using multivariable logistic regression. A derivation cohort (n=311, 75%) was used to develop the prediction models. The models were tested by a validation cohort (n=104, 25%). RESULTS: The median age was 66 years (Interquartile range [IQR] 54-77) and the majority were male (55%) and non-White (65.8%). The 14-day severe COVID-19 rate was 39.3%; 31.7% required ICU, 24.6% mechanical ventilation, and 21.2% died. Machine learning algorithms and clinical judgment were used to improve model performance and clinical utility, resulting in the selection of eight predictors: age, sex, dyspnea, diabetes mellitus, troponin, C-reactive protein, D-dimer, and aspartate aminotransferase. The discriminative ability was excellent for both the severe COVID-19 (training area under the curve [AUC]=0.82, validation AUC=0.82) and mortality (training AUC= 0.85, validation AUC=0.81) models. These models were incorporated into a mobile-friendly website. CONCLUSIONS: This web-based risk prediction model can be used at the bedside for prediction of severe COVID-19 using data mostly available at the time of presentation. |
format | Online Article Text |
id | pubmed-8141270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Southern Society for Clinical Investigation. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81412702021-05-24 Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model Woo, Sang H. Rios-Diaz, Arturo J. Kubey, Alan A. Cheney-Peters, Dianna R. Ackermann, Lily L. Chalikonda, Divya M. Venkataraman, Chantel M. Riley, Joshua M. Baram, Michael Am J Med Sci Clinical Investigation BACKGROUND: Coronavirus disease 2019 (COVID-19) carries high morbidity and mortality globally. Identification of patients at risk for clinical deterioration upon presentation would aid in triaging, prognostication, and allocation of resources and experimental treatments. RESEARCH QUESTION: Can we develop and validate a web-based risk prediction model for identification of patients who may develop severe COVID-19, defined as intensive care unit (ICU) admission, mechanical ventilation, and/or death? METHODS: This retrospective cohort study reviewed 415 patients admitted to a large urban academic medical center and community hospitals. Covariates included demographic, clinical, and laboratory data. The independent association of predictors with severe COVID-19 was determined using multivariable logistic regression. A derivation cohort (n=311, 75%) was used to develop the prediction models. The models were tested by a validation cohort (n=104, 25%). RESULTS: The median age was 66 years (Interquartile range [IQR] 54-77) and the majority were male (55%) and non-White (65.8%). The 14-day severe COVID-19 rate was 39.3%; 31.7% required ICU, 24.6% mechanical ventilation, and 21.2% died. Machine learning algorithms and clinical judgment were used to improve model performance and clinical utility, resulting in the selection of eight predictors: age, sex, dyspnea, diabetes mellitus, troponin, C-reactive protein, D-dimer, and aspartate aminotransferase. The discriminative ability was excellent for both the severe COVID-19 (training area under the curve [AUC]=0.82, validation AUC=0.82) and mortality (training AUC= 0.85, validation AUC=0.81) models. These models were incorporated into a mobile-friendly website. CONCLUSIONS: This web-based risk prediction model can be used at the bedside for prediction of severe COVID-19 using data mostly available at the time of presentation. Southern Society for Clinical Investigation. Published by Elsevier Inc. 2021-10 2021-05-23 /pmc/articles/PMC8141270/ /pubmed/34029558 http://dx.doi.org/10.1016/j.amjms.2021.04.001 Text en © 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Clinical Investigation Woo, Sang H. Rios-Diaz, Arturo J. Kubey, Alan A. Cheney-Peters, Dianna R. Ackermann, Lily L. Chalikonda, Divya M. Venkataraman, Chantel M. Riley, Joshua M. Baram, Michael Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model |
title | Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model |
title_full | Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model |
title_fullStr | Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model |
title_full_unstemmed | Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model |
title_short | Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model |
title_sort | development and validation of a web-based severe covid-19 risk prediction model |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141270/ https://www.ncbi.nlm.nih.gov/pubmed/34029558 http://dx.doi.org/10.1016/j.amjms.2021.04.001 |
work_keys_str_mv | AT woosangh developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT riosdiazarturoj developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT kubeyalana developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT cheneypetersdiannar developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT ackermannlilyl developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT chalikondadivyam developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT venkataramanchantelm developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT rileyjoshuam developmentandvalidationofawebbasedseverecovid19riskpredictionmodel AT barammichael developmentandvalidationofawebbasedseverecovid19riskpredictionmodel |